Algeta to Participate in Upcoming Investor Conferences

OSLO, Norway, Nov. 5, 2013 (GLOBE NEWSWIRE) --

Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its executive management team will participate in the following upcoming investor conferences: Credit Suisse Healthcare Conference 2013 Date: 12-14 November 2013 Participants: Jeff Albers (President, Algeta US) Mike Booth (SVP, Communications) Venue: Scottsdale, AZ, USA DNB Markets Health Care Conference Date: 27 November 2013 Participants: Andrew Kay (President & CEO) Thomas Ramdahl (Executive VP and COO) Venue: Oslo, Norway Deutsche Bank dbAccess Pharmaceutical Corporate Day Date: 5 December 2013 Participants: Andrew Kay (President & CEO) Mike Booth (SVP, Communications) Venue: London, UK SEB Securities Best of Norway Day Date: 12 December 2013 Participants: Mike Booth (SVP, Communications) Venue: New York, NY, USA Presentations, where applicable, will be available to download at following these events. ### For further information, please contact: Mike Booth +1 646 410 1884 Communications & Corporate Affairs Media enquiries: Mark Swallow +44 207 638 9571 Citigate Dewe Rogerson Knut Ekern +47 22 04 82 00 Gambit Hill & Knowlton Kari Watson +1 781 235 3060 MacDougall Biomedical Communications Investor enquiries: Tricia Truehart +1 646 378 2953 The Trout Group About Algeta Algeta is a company focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit Press release: [HUG#1740508] Source:Algeta ASA